Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 153,298 | 99,119 | 86,810 | 35,545 | 104,139 |
| Marketable Securities | 125,283 | 136,069 | 133,956 | 138,454 | 184,512 |
| Receivables | 105,556 | 96,956 | 99,079 | 93,205 | 98,397 |
| Inventories | 104,353 | 96,520 | 92,130 | 92,977 | 96,063 |
| TOTAL | $509,994 | $447,255 | $429,324 | $376,114 | $498,334 |
| Non-Current Assets | |||||
| PPE Net | 173,927 | 175,783 | 180,310 | 181,617 | 183,512 |
| Investments And Advances | 38,459 | 0 | 0 | 8,281 | 37,209 |
| Intangibles | 646,501 | 660,823 | 675,145 | 689,467 | 703,789 |
| Other Non-Current Assets | 205,505 | 250,601 | 257,602 | 267,939 | 258,356 |
| TOTAL | $1,064,392 | $1,087,207 | $1,113,057 | $1,147,304 | $1,182,866 |
| Total Assets | $1,574,386 | $1,534,462 | $1,542,381 | $1,523,418 | $1,681,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,641 | 8,641 | 19,504 | 10,853 | 33,648 |
| Accounts payable and accrued liabilities | 15,698 | 16,511 | 24,206 | 17,261 | 15,220 |
| Accrued Expenses | 64,243 | 59,884 | 56,221 | 61,633 | 89,785 |
| TOTAL | $97,383 | $93,661 | $108,912 | $98,698 | $147,774 |
| Non-Current Liabilities | |||||
| Long Term Debt | 115,202 | 117,965 | 134,823 | 137,534 | 251,056 |
| Other Non-Current Liabilities | 491,671 | 491,285 | 490,671 | 519,145 | 507,360 |
| TOTAL | $606,873 | $609,250 | $625,494 | $656,679 | $758,416 |
| Total Liabilities | $704,256 | $702,911 | $734,406 | $755,377 | $906,190 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,501 | 46,438 | 46,417 | 45,989 | 45,952 |
| Common Shares | 46 | 46 | 46 | 46 | 46 |
| Retained earnings | -106,796 | -131,666 | -142,524 | -168,287 | -148,751 |
| Other shareholders' equity | 247 | -10 | -173 | -137 | -380 |
| TOTAL | $870,130 | $831,551 | $807,975 | $768,041 | $775,010 |
| Total Liabilities And Equity | $1,574,386 | $1,534,462 | $1,542,381 | $1,523,418 | $1,681,200 |